Browse thousands of immunization resources shared by TechNet members
Agenda - GVIRF 2014
KN1 Opening Session and Keynote
KN2 Research for Universal Health Coverage; Perspective on Vaccines and Poverty Reduction
KN3 Importance of Innovation in Addressing Global Health Gaps in the Developing World
P1b Develop New and Improved Vaccines - TB
P1c Develop New and Improved Vaccines - Malaria
P2 Regulatory and Public Health Challenges for Vaccines Inducing Modest Efficacy
P3 Developing Next Generation Vaccines: Defining the Improvements Needed and Evaluating Their Potential
P5 Research to improve monitoring and evaluation of immunization programs
P6 Protection of pregnant women, neonates and infants by maternal immunization
P7 Innovative vaccine research: the point of view of industry and biotech companies
P8 General Conclusion
W1 Towards the Development of a Universal Influenza Vaccine
W2 Preferred Product Characteristics (PPC) as a Way to Guide Development of Products of High Public Health Utility
W4 How to Optimize Immunization Coverage? A case study from Measles-Rubella vaccination
W6 Innovation in vaccine delivery and presentation: How can technological advances increase program performance?
W7 Contributions of Regulatory Science to Vaccine Access
W8 Systems Vaccinology
KN1.1 Vaccine Research and Development: Challenges and Opportunities
KN1.2 R&D in the "Decade of Vaccines"
KN1.3 GVIRF Overview and Goals
KN1.4 What do we expect from the meeting?
KN2.1 WHO Director-General address to GVIRF
KN2.2 Perspectives on Vaccines and Poverty Reduction
KN3-1 The Importance of Innovation in Addressing Global Health Gaps in the Developing World
P1a.1 Status of HIV Vaccine Research & Development
P1a.2 Progress towards the development of an HIV vaccine: Discussion
P1b.1 Update on Tuberculosis Vaccines - 2014
P1b.2 TB Vaccine Development: Challenges & Opportunities
P1c.1 Progress towards the development of a malaria vaccine
P1c.2 Progress towards the development of a malaria vaccine: discussion
P2.1 Regulatory and public health challenges
P2.2 Regulatory Considerations for Determining Vaccine Efficacy
P3.1 Developing next generation vaccines: Introduction
P3.2 Developing Country Vaccine Manufacturers - Access to Immunization
P3.3 Developing Next Generation Rotavirus Vaccines: Prospects from the Pipeline to Address Remaining Public Health Needs
P3.4 Evaluation of the Next Generation of Rotavirus Vaccines
P5.1 Immunization Registries in Latin America and the Caribbean
P5.2 Influenza Vaccine Use in the Americas: Network for Evaluation of Influenza Vaccine Effectiveness REVELAC-1
P6.1 Public Health Benefits of Maternal Immunization
P6.2 Maternal Immunization: which impact on infant immunity?
P7.1 Innovation for vaccines against poverty diseases: the need for new support mechanisms
W1.1 Towards the Development of a Universal Influenza Vaccine
W2.1 WHO Preferred Product Characteristics: Bridging Vaccine R&D with Public Health
W2.2 RSV Vaccine Development for Low and Middle Income Countries: Challenges and Progress
W2.3 Group A streptococcal vaccines: Challenges and progress
W3.1 Leishmania Vaccine Development: Progress and challenges in the context of other control strategies
W3.2 Pre-exposure rabies vaccination (PreP) in children of endemic countries
W4.1 Progress, Challenges, and Lessons Learned in Achieving Measles and Rubella Goals
W4.2 Prioritizing the Research Agenda for Measles and Rubella
W5.1 Immunization implementation research priority setting
W5.2 Factors influencing community health volunteers in participating in health programs in Africa
W5.3 Strengthening national capacity for evidence-based immunization policy: the case of program costing in Honduras
W5.4 Building Implementation Research Capacity for Polio Eradication
W6.1 WHO - Next-generation Vaccine Delivery Technology Meeting Summary
W6.2 Beyond the cold chain… Meningitis A conjugate vaccine in a controlled temperature chain: Experience from Benin
W6.3 Case Study: The Uniject Injection System
W7.1 Contributions of Regulatory Science to Vaccine Access
W7.2 Enhancement in Laboratory Research to Support Innovations in Regulatory Science for the Evaluation of New Vaccines
W7.3 How can innovation in regulatory science inform the regulatory process to facilitate the development of new vaccines?
W8.1 How can recent technological advances in systems vaccinology accelerate next-generation vaccine development?
W8.2 Systems Vaccinology
W8.3 Application of technological advances to clinical trials
Conference Report